Pharmacology for renal calculi

Expert Opinion on Pharmacotherapy

Volumn 1, Issue 3, 2000, Pages 435-441

  Blair, Bryan ^a   Fabrizio, Michael ^b  

^a NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Kidney stones; Medical therapy; Metabolic evaluation; Nephrolithiasis; Renal calculi

Indexed keywords

CALCIUM OXALATE; CYSTINE; URINARY TRACT AGENT;

HUMAN; METABOLISM; NEPHROLITHIASIS; REVIEW;

CALCIUM OXALATE; CYSTINE; HUMANS; KIDNEY CALCULI; RENAL AGENTS;

EID: 0034157885     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.1.3.435     Document Type: Review

References (29)

1. WESHUB LP: Urology: From Antiquity to the 20th Century. Warren H Green (Ed.), St. Louis, MO, USA (1970). Accounts history of understanding of stone disease.
2. WALSH PC: Urinary lithiasis: Etiology, Diagnosis, and Medical Management. In: Urology Vol. III. Menon M, Parulkar B, Drach G (Eds.), WB Saunders, Inc., Philadelphia, USA (1998) Chapter 91.
3. CURHAN GC, WILLETT WC, RIMM ED et al.: Prospective study of beverage use and risk of kidney stones. Am. J. Epidemiol. (1996) 143:240-247.
4. STRAUS A, COE FL, DEUTSCH L, PARKS JH: Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am. J. Med. (1982) 72:17-24.
5. SAKLAHEE K, HARVEY JA, PADALINNO PK et al.: The potential role of self advice on the risk of kidney stone formation. J. Urol. (1993) 150:310-312.
6. CURHAM GC, WILLETT WC, RIMM EB, STUMPFER MJ: A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N. Engl. J. Med. (1993) 328:833-838.
7. PAK CYC: Hypercalciuria calcium nephrolithiasis. In: Urolithiasis: A Medical and Surgical Reference. Resnick MI, Pack CYC (Eds.), WB Saunders, Philadelphia, USA (1990):79-88.
8. COE FL, PAKS JH, BUSHINSKY DA et al.: The pathogenisis and treatment of kidney stones. N. Engl. J. Med. (1992) 327:1141-1152.
9. LAMINSKI MA, MEYERS AM, KRUGER M et al.: Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors. Br. J. Urol. (1991) 61:454-458.
10. HAYASHI Y, KAPLAN RA, PAK CYC: Effect of cellulose phosphate therapy on crystallization of calcium oxalate in urine. Metabolism (1978) 24:1273-1278.
11. YENTA ER, GAGE RJ, COHERING M: The effects of thiazides in idiopathic hypercalciuria. Am. Med. Sci. (1966) 251:409-416.
12. YENDT ER, COHANIM M: Prevention of calcium stones with thiazides. Kidney Int. (1978) 13:397-409.
13. PREMINGER GM: Medical management of urinary calculus disease: Part II. Classification of metabolic disorders and selective medical management. AUA Update Series (1995) 14:1-8.
14. ASSIMOS DG. HOLMES RP, GOODMAN HO: Hypercalciuria advances in medical therapy. Contemp. Urol. (1997):47.
15. ETINGER B: Recurrent nephrolithiasis: natural history and effect of phosphate therapy A double-blind controlled study. Am. J. Med. (1976) 61:200-206.
16. PAK CYC: Medical management of nephrolithiasis. J. Urol. (1982) 128:1157-1164.
17. DRETLER SP: The physiological approach to the medical management of stone disease. Urol. Clin. N. Am. (1998) 25(Suppl. 4):613-623.
18. ETTINGER B, TANY A, CITRON JT et al.: Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N. Engl. J. Med. (1986) 315:1386-1389.
19. HOFBAUER J, HOBARTH R, SZABO N, MARBERGER M: Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis, a prospective randomized study. Br. J. Urol. (1994) 73:362-365.
20. ABDULHEDI MH, HALL PM, STREEM SB: Can citrate therapy prevent nephrolithiasis? Urology (1993) 91:221-224.
21. SAKHASE K, NICOR M, HILL K, PAK CYC: Contrasting effects of potassium citrate and sodium citrate therapies on urinary diminishing and crystallization of stone forming salts. Kidney Int. (1983) 24:348-352.
22. MELNICK I, LANDES RR, HOFFMAN AA, et al.: Magnesium therapy for recurring calcium oxalate urinary calculi. J. Urol. (1971) 17:420-425.
23. ETTINGER B, CITRON JR, LIVERONE B, DOLMAN LI: Chlorthalidone reduces calcium oxalate calculus recurrence but magnesium hydroxide does not. J. Urol. (1998) 89:679-684.
24. WILSON DR, STRAUSS AL, MAUEL MA: Comparison of medical treatments for the prevention of recurrent calcium nephrolithiasis. Urol. Res. (1984) 12:39-40.
25. COHEN TD, PREMINGER GM: Struvite calculi. Semin. Nephrol. (1996) 16:425-434.
26. HEIMBACH D, BAUMLER D, SCHOENEICH G, HESSE A: Percutaneous chemolysis. An important tool in the treatment of urolithiasis. Intl. Urol. Nephrol. (1998) 30:655-664.
27. SHORR E, CARTER AC: Aluminium gels in the management of renal phosphatic calculi. JAMA (1950) 144:1549-1556.
28. RUTCHIK SD, RESNICK MI: Cystine calculi, diagnosis and management. Urol. Clin. N. Am. (1997) 24:163-171.
29. SAKLAHEE K: Pathogenesis and medical management of cystinuria. Semin. Nephrol. (1996) 61(Suppl. 5):435-447.